Novo Holdings A/S holds a focused book of 25 stocks worth $1.7B as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). The SEC 13F shows only Novo Holdings A/S's US-listed positions. Its main portfolio is mostly Copenhagen-listed and does not appear in this book. This quarter they trimmed Mirum Pharmaceuticals Inc. Their largest long position is Edgewise Therapeutics Inc at 13% of the equity book.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
91% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Novo Holdings A/S
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 28 / 25 | $10.2B |
| UBS Group AG | 28 / 25 | $4.6B |
| GEODE CAPITAL MANAGEMENT, LLC | 27 / 25 | $6.3B |
| BlackRock, Inc. | 26 / 25 | $24.6B |
| WELLS FARGO & COMPANY/MN | 26 / 25 | $2.2B |
| BNP PARIBAS FINANCIAL MARKETS | 26 / 25 | $1.6B |
| CITIGROUP INC | 26 / 25 | $1.5B |
| XTX Topco Ltd | 26 / 25 | $56.8M |
Ranked by how many of Novo Holdings A/S's top 25 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1388325/holdings"
Use Arkolith to show Novo Holdings A/S's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.